ATON
AlphaTONยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ATON Profile
Alphaton Capital Corp
A clinical stage immunooncology company
Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110
--
AlphaTON Capital Corp was incorporated in Ontario in 1973. AlphaTON is a clinical-stage immuno-oncology company that believes it will be a first-in-class therapy for cancer avoidance in patients with known checkpoint resistance pathways to improve long-term treatment response and quality of life. AlphaTON is currently working on nine immuno-oncology assets, five of which are in the preclinical stage and four in the clinical stage. AlphaTON drug development pipeline products include biological-based product candidates or technologies to address known resistance pathways/mechanisms of current checkpoint inhibitors based on identified scientific principles, including intratumoral delivery, nanoparticles, liposomes, aptamers and virus-like particles.
